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Hypertensive Nephropathy S25dependent manner. AT1R silence effectively blocked Ang II-induced damage.
MitoTEMPO attenuated the activation of NRLP3 inflammasome through clear-
ance of reactive oxygen species (ROS). Moreover, Ang II-induced mitochon-
drial dysfunction was markedly inhibited by silence of NLRP3.
Conclusion: Ang II stimulation induces NLRP3 inflammasome activation
through AT1a receptor. Ang II-induced NLRP3 activation is mediated by mito-
chondrial dysfunction, with overproduction and accumulation of ROS. NLRP3
inflammasome activation plays an important role in kidney injury, and block-
ing it can be a potential therapeutic target for hypertension-associated kid-
ney damage.http://dx.doi.org/10.1016/j.hkjn.2015.08.0770220
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Objective: To Identify the clinical and pathological characteristics of 75 Chi-
nese patients with benign hypertensive nephrosclerosis (BHN) and the rela-
tionship between the clinical and pathological changes.
Methods: BHN patients proved by renal biopsy were retrospectively
analyzed based on the clinical and pathological records. Glomerular lesions
were divided into five types: hypertrophic, focal segmental sclerotic, solid-
ified or ischemic (including wrinkled and obsolescent changes). Patients
were grouped for further analysis according to whether eGFR  60 ml/
min/1.73 m2,  30% ischemic glomeruli,  20% obsolescent glomeruli,
respectively.
Results: 75 BHN patients with an average age of 44.4 10.7 years, M/F 4:1.
eGFR had significant negative correlation with systolic blood pressure (SBP)
(rZ0.276, PZ 0.016) but not diastolic blood pressure (DBP). DBP had sig-
nificant negative correlation with age (rZ0.3, PZ 0.007). The most com-
mon pathological type of glomerular lesion was ischemic (30.6%), including
ischemic wrinkled (13%) and obsolescent (17.6%). Arteriolar stenosis had sig-
nificant positive correlation with ischemic glomerular lesion (rZ 0.33,
PZ 0.004), but not obsolescent glomeruli. Multivariate analysis showed:
(1) SBP rather than DBP was independent risk factor of eGFR decline; (2) in-
dependent associated factors of ischemic glomerular change were TG
(ORZ 1.78, 95% CI 1.02w3.1; PZ 0.041), age (ORZ 0.93, 95% CI
0.89w0.99; PZ 0.018) and eGFR (ORZ 0.97, 95% CI 0.95w0.99;
PZ 0.004); (3) independent associated factors of obsolescent glomeruli
were TG (ORZ 1.96, 95% CI 1.13w3.4; PZ 0.016) and eGFR (ORZ 0.97,
95% CI 0.95w0.99; PZ 0.012).
Conclusion: SBP is independent risk factor of eGFR decline in BHN. TG pro-
moted the development of ischemic and obsolescent glomerular lesion
which may offer a new therapeutic target for the management of BHN.http://dx.doi.org/10.1016/j.hkjn.2015.08.078
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Objective: Chronic kidney disease (CKD) is highly prevalent in Taiwan.
More than two-thirds of end-stage renal disease is associated with diabetes
mellitus (DM) or hypertension (HTN). Therefore, the formulation of aspecial preventative policy of CKD in these patients is essential. This study
surveyed 14 traditional risk factors and identified their effects on CKD in
patients with HTN/DM and compared these with their effects in the gen-
eral population.
Methods: This study included 5328 cases and 5135 controls in the CKD/HTN/
DM outpatient centers of 10 hospitals in Taiwan. Fourteen common effect
factors were surveyed (four demographic, five disease and five lifestyle),
and their effects on CKD were tested. Significance tests were adjusted by
the Bonferroni method. Results of the stratified analyses in the variables
were presented with significant heterogeneity between patients with
different comorbidities.
Results: Male, ageing, low income, hyperuricemia and lack of exercise
habits were risk factors for CKD, and their effects in people with different
comorbidities were identical. Anemia was a risk factor, and there was an ad-
ditive effect between anemia and HTN on CKD. Patients with anaemia had a
higher risk when associated with HTN [odds ratio (OR)Z 6.75, 95% CI
4.76e9.68] but had a smaller effect in people without HTN (OR 2.83, 95%
CI 2.16e3.67). The association between hyperlipidaemia-related factors
and CKD was also moderated by HTN. It was a significant risk factor in people
without HTN (ORZ 1.67, 95% CI 1.38e2.01) but not in patients with HTN
(ORZ 1.03, 95% CI 0.89e1.19). Hepatitis B, hepatitis C, betel nut chewing,
smoking, alcohol intake and groundwater use were not associated with CKD
in multivariate analysis.
Conclusion: We considered that patients with HTN and anemia were a
high CKD risk population. Physicians with anemic patients in outpatient
clinics need to recognize that patients who have HTN might be latent
CKD cases.http://dx.doi.org/10.1016/j.hkjn.2015.08.0790240
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Objective: Chronic kidney disease (CKD) is an independent risk factor for
cardiovascular disease. Although pulse wave velocity (PWV), which reflects
arterial stiffness, was increased in subjects with CKD, little is known
regarding whether arterial stiffness can increase the risk of CKD. To help
clarify this, we conducted a prospective cohort study to measure the associ-
ation of arterial stiffness with CKD.
Methods: A total of 7455 adults who visited the Health Checkup Clinic
consecutively were enrolled from April 2010 to December 2010. 92 partici-
pants with proteinuria, and 108 participants with decreased eGFR calculated
by the CKD-EPI equation (eGFR < 60 ml/min/1.73 m2) at baseline were
excluded. CKD was defined as decreased eGFR or presence of proteinuria
(urine protein  1+). During the follow-up, 43 participants were lost to
follow-up. 58 participants were excluded from ananlysis due to insufficient
blood or urine samples, 7154 participants aged 54.8 10.6 years without
CKD at baseline were enrolled in the final ananlysis. Arterial stiffness was
evaluated by carotid-femoral PWV (cfPWV) using the SphygmoCor device
(AtCor Medical Ltd., Sydney, Australia).
Results: During 3 years of follow-up, 167 (2.3%) patients developed CKD,
101 (1.4%) patients with proteinuria and 68 (1.0%) patients with decreased
eGFR. After adjusting for potential confounders, either cfPWV (per 1cm/s
increase) or the highest quartile of cfPWV (increased cfPWV) was indepen-
dently associated with increased risk of proteinuria and CKD (P< 0.05). By
contrast, neither cfPWV (per 1 cm/s increase) nor increased cfPWV was
associatied with decreased eGFR in the multivariable logistic regression
analysis.
Conclusion: This study revealed that arterial stiffness increases the risk of
CKD. Hence, high-risk patients with arterial stiffness should have targeted
monitoring for the development of CKD.
http://dx.doi.org/10.1016/j.hkjn.2015.08.080
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Table 1 Clinical characteristics of participants stratified according to the qurtiles of cfPWV.
Total Quartile 1 Quartile 2 Quartile 3 Quartile 4 P value
Number 7154 1764 1811 1797 1782
Age (years) 54.8 10.6 46.9 8.2 51.1 7.6 56.7 8.6 64.2 9.0 < 0.001
Male (n, %) 5191 (72.6) 1010 (57.3) 1370 (75.6) 1399 (77.9) 1412 (79.2) < 0.001
BMI (kg/m2) 25.5 3.3 24.5 3.2 25.4 3.2 25.9 3.2 26.0 3.2 < 0.001
Current smoking (n, %) 4688 (65.5) 1299 (75.2) 1083 (61.3) 1113 (62.8) 1193 (68.2) < 0.001
Habitual driking (n, %) 3536 (49.4) 770 (44.7) 1012 (57.6) 960 (54.6) 794 (45.6) < 0.001
Hypertension (n, %) 2785 (38.9) 129 (7.3) 418 (23.2) 880 (49.3.3) 1358 (76.6) < 0.001
Diabetes (n, %) 814 (11.4) 62 (3.5) 151 (8.3) 226 (12.6) 375 (21.0) < 0.001
Blood glucose (mmol/L) 5.9 1.4 5.4 0.9 5.7 1.2 6.0 1.5 6.4 1.6 < 0.001
SBP (mmHg) 135.5 19.7 120.0 13.3 130.0 14.2 139.8 16.3 152.6 18.0 < 0.001
DBP (mmHg) 78.8 11.4 71.8 9.1 77.9 10.0 81.6 11.1 83.7 11.6 < 0.001
Hemoglobin (g/L) 145.4 13.8 140.8 14.9 145.5 13.5 147.3 13.2 147.7 12.3 < 0.001
Serum albumin (g/L) 43.2 2.8 42.8 2.7 43.7 2.6 43.3 3.3 42.6 2.9 0.68
BUN (mmol/L) 5.2 1.3 5.0 1.2 5.1 1.2 5.3 1.2 5.3 1.3 < 0.001
Serum creatinine (mmol/L) 76.7 12.3 75.5 12.3 77.7 11.6 77.1 12.4 76.7 12.9 < 0.001
UA (mmol/L) 313.3 88.7 295.1 86.4 324.1 91.5 319.5 89.1 313.9 84.8 < 0.001
Total cholesterol (mmol/L) 5.12 0.90 4.92 0.85 5.13 0.89 5.20 0.89 5.26 0.94 < 0.001
Triglycerides（mmol/L） 1.51 1.16 1.24 0.89 1.54 1.19 1.65 1.31 1.61 1.18 < 0.001
LDL cholesterol (mmol/L) 3.12 0.60 2.99 0.57 3.12 0.57 3.16 0.61 3.21 0.63 < 0.001
HDL cholesterol (mmol/L) 1.38 0.26 1.36 0.25 1.35 0.24 1.39 0.27 1.42 0.28 < 0.001
eGFR (ml/min/1.73m2) 96.5 13.1 102.0 12.3 99.4 11.5 95.1 12.1 89.5 12.7 < 0.001
cfPWV (cm/s) 1513.2 301.7 1203.3 78.3 1370.4 40.4 1546.9 64.7 1930.9 249.2 < 0.001
6eGFR (ml/min/1.73m2) 5.1 10.7 7.0 10.5 5.9 10.5 4.4 10.5 3.0 10.7 < 0.001
Proteinuria (n, %) 101 (1.4) 9 (0.5) 13 (0.7) 25 (1.4) 54 (3.0) < 0.001
deGFR (n, %) 68 (1.0) 5 (0.3) 9 (0.5) 20 (1.1) 34 (1.9) < 0.001
CKD (n, %) 167 (2.3) 14 (0.8) 22 (1.2) 45 (2.5) 86 (4.8) < 0.001
Abbreviation: cfPWV, carotid-femoral pulse wave velocity; The 25, 50 and 75 percentile for cfPWV was 1307.0, 1445.0 and 1667.0 (cm/s), respectively; BMI,
body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; BUN, urea nitrogen; UA, uric acid; LDL, low-desity lipoprotein; HDL, high-
desity lipoprotein; eGFR, estimated glomerular filtration rate; 6eGFR, change in eGFR; deGFR, decreased estimated glomerular filtration rate; CKD,
chronic kidney disease.
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Table 2 Multivariate logistic regression analysis for association between cfPWV with indicators of kidney damage.
Participants Crude OR
(95% CI)
Age- and sex-adjusted OR
(95% CI)
Multivariable adjusted OR1a
(95% CI)
Multivariable adjusted OR2b
(95% CI)
CKD (nZ 167)
cfPWV (per 1cm/s increase) 1.002 (1.001e1.002) 1.001 (1.001e1.002) 1.001 (1.0e1.001) 1.001 (1.0e1.001)
cfPWV (quartiles)
Quartile 1 Ref Ref Ref Ref
Quartile 2 1.54 (0.78e3.01) 1.38 (0.70e2.72) 1.21 (0.61e2.40) 1.33 (0.64e2.73)
Quartile 3 3.21 (1.75e5.86) 2.41 (1.28e4.54) 1.79 (0.93e3.45) 1.74 (0.86e3.53)
Quartile 4 6.34 (3.60e11.20) 3.77 (1.96e7.25) 2.23 (1.10e4.51) 2.22 (1.05e4.69)
Proteinuria (nZ 101)
cfPWV (per 1cm/s increase) 1.002 (1.001e1.002) 1.002 (1.001e1.003) 1.001 (1.001e1.002) 1.001 (1.001e1.001)
cfPWV (quartiles)
Quartile 1 Ref Ref Ref Ref
Quartile 2 1.41 (0.60e3.31) 1.48 (0.63e3.51) 1.21 (0.51e2.90) 1.34 (0.52e3.45)
Quartile 3 2.75 (1.28e5.91) 3.04 (1.36e6.78) 1.95 (0.84e4.54) 1.96 (0.78e4.92)
Quartile 4 6.09 (3.0e12.38) 7.18 (3.17e16.30) 3.40 (1.38e8.35) 3.29 (1.25e8.67)
deGFR (nZ 68)
cfPWV (per 1cm/s increase) 1.002 (1.001e1.002) 1.0 (0.99e1.001) 1.0 (0.99e1.001) 1.0 (0.99e1.001)
cfPWV (quartiles)
Quartile 1 Ref Ref Ref Ref
Quartile 2 1.76 (0.59e5.25) 1.25 (0.42e3.79) 1.21 (0.40e3.68) 1.18 (0.39e3.59)
Quartile 3 3.96 (1.48e10.56) 1.64 (0.59e4.57) 1.50 (0.52e4.28) 1.32 (0.45e3.85)
Quartile 4 6.84 (2.67e17.54) 1.43 (0.50e4.13) 1.22 (0.40e3.74) 1.18 (0.38e3.69)
Abbreviation: CKD, chronic kidney disease; OR, odds ratio; CI, confidence interval; cfPWV, carotid-femoral pulse wave velocity; deGFR, decreased esti-
mated glomerular filtration rate.
The 25, 50 and 75 percentile of cfPWV was 1307.0, 1445.0 and 1667.0 (cm/s), respectively. The 25, 50 and 75 percentile of uric acid for male was 282.0,
333.0 and 390.0mmol/L, respectively. The 25, 50 and 75 percentile of uric acid for female was 199.0, 244.0, 290.0mmol/L, respectively.
a OR1 was adjusted for age, sex, hypertension, diabetes.
b OR2 was adjusted for age, sex, hypertension, diabetes, BMI, uric acid (analyzed in sex-specific quartiles), current smoking, habitual drinking, total
cholesterol, triglycerides, LDL cholesterol and HDL cholesterol.
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